Answer
Panitumumab is licensed for wild-type RAS metastatic colorectal cancer. RAS mutations can keep growth signalling active despite EGFR blockade.
Sources for this answer
- Vectibix 20 mg/mL concentrate for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.